6,7-Bis- (2-methoxyethoxy) -4 (3H) -quinazolinone CAS 179688-29-0

Khoom Piav Qhia:

Khoom Lub Npe: 6,7-Bis- (2-methoxyethoxy) -4 (3H) -quinazolinone CAS TSIS TAU: 179688-29-0

Lub ntsiab lus:

Erlotinib Intermediate V;

6,7-Bis (2-methoxyethoxy) -3,4-dihydroquinazolin-4-ib;

6,7-di (2' -methoxyethoxy) quinazolin-4 (3H) -one;

Tshuaj& Lub Cev Muaj Zog:

Tsos: Dawb rau dawb-dawb khoom

Kev Ntsuas: ≥99.00%

Ceev: 1.26 g/cm3

Kub Point: 467.8 ℃ ntawm 760 mmHg

Melting Point: 185-189 ℃

Flash Point: 236.7 ℃

Refractive Index: 1.552

Vapor Siab: 6.3E-09mmHg ntawm 25 ℃

Cia txias: -20 ℃ Lub freezer

Solubility: DMSO: ≥10mg/ml

Cov Ntaub Ntawv Kev Nyab Xeeb:

HS Code: 2933990090

Lo Lus Teeb: Ceeb Toom

WGK Lub Tebchaws Yelemees: 3

Cov lus ceeb toom ua ntej: P261-P305+P351+P338

Cov Lus Qhia Teeb Meem: H315-H319-H335

Ib nrab ntawm cov synthesis ntawm Erlotinib (E625000). CP-380736 yog ib qho kev tiv thaiv ntawm cov txheej txheem kev loj hlob ntawm daim tawv nqaij (EGFR). EGFR yog tyrosine kinase uas qhib MAPK, JNK, thiab Akt txoj hauv kev, thiab yog tus kws kho mob tseem ceeb ntawm ntau hom mob qog noj ntshav, suav nrog mob qog noj ntshav hauv ntsws thiab glioblastoma multiforme.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam nyob rau hauv patent tau muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm zaum kawg tshwj xeeb tshaj yog nrog tus neeg yuav khoom.

Cim npe nrov: 6,7-bis- (2-methoxyethoxy) -4 (3h) -quinazolinone cas 179688-29-0, tuam ntxhab, cov chaw muag khoom, lub Hoobkas, yuav, hauv Tshuag

• Tug: 4-Chloro-6,7-bis (2-methoxyethoxy) quinazoline CAS 183322-18-1
• Tom ntej: 2-Amino-4,5-bis (2-methoxyethoxy) benzoic Acid Ethyl Ester Hydrochloride CAS 183322-17-0